drugset
drugset / Trial / NCT04365257

Prazosin to Prevent COVID-19 (PREVENT-COVID Trial)

NCT04365257 ↗

Phase 2 Terminated 5 enrolled Johns Hopkins University Fast Grants · collab
RandomizedParallel-groupOpen-labelTreatment

Summary

The purpose of this study is to assess the efficacy and safety of prazosin to prevent cytokine storm syndrome and severe complications in hospitalized patients with Coronavirus disease 2019 (COVID-19).

Timeline

Start
2020-05-13
Primary completion
2022-03-31
Completion
2022-03-31

Drugs

EvaluationDrugModalityDoseRoute
Subject Prazosin Unknown 5 mg —

Indications

COVID-19